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Autophagy plays critical but diverse roles in cellular quality control and homeostasis
potentially checking tumor development by removing mutated or damaged
macromolecules, while conversely fostering tumor survival by supplying essential
nutrients during cancer progression. This report documents a novel inhibitory role for
a lysosome-associated membrane protein, LAMP-2C in modulating autophagy and
melanoma cell growth in vitro and in vivo. Solid tumors such as melanomas encounter
a variety of stresses in vivo including inflammatory cytokines produced by infiltrating
lymphocytes directed at limiting tumor growth and spread. Here, we report that in
response to the anti-tumor, pro-inflammatory cytokine interferon-gamma, melanoma
cell expression of LAMP2C mRNA significantly increased. These results prompted
an investigation of whether increased melanoma cell expression of LAMP-2C might
represent a mechanism to control or limit human melanoma growth and survival. In
this study, enhanced expression of human LAMP-2C in melanoma cells perturbed
macroautophagy and chaperone-mediated autophagy in several human melanoma
lines. In vitro analysis showed increasing LAMP-2C expression in a melanoma cell line,
triggered reduced cellular LAMP-2A and LAMP-2B protein expression. Melanoma cells
with enhanced LAMP-2C expression displayed increased cell cycle arrest, increased
expression of the cell cycle regulators Chk1 and p21, and greater apoptosis and
necrosis in several cell lines tested. The increased abundance of Chk1 protein in
melanoma cells with increased LAMP-2C expression was not due to higher CHEK1
mRNA levels, but rather an increase in Chk1 protein abundance including Chk1
molecules phosphorylated at Ser345. Human melanoma cell xenografts with increased
LAMP-2C expression, displayed reduced growth in immune compromised murine
hosts. Melanomas with high LAMP-2C expression showed increased necrosis and
reduced cell density upon histological analysis. These results reveal a novel role for
LAMP-2C in negatively regulating melanoma growth and survival.
Keywords: LAMP-2, LAMP-2C, macroautophagy, chaperone-mediated autophagy, melanoma, tumor
Abbreviations: Chk1, checkpoint kinase 1; CMA, chaperone-mediated autophagy; CQ, chloroquine; HSC70, heat shock
cognate protein 70; HSP90, heat shock protein 90; IFN-γ, interferon-gamma; LAMP, lysosome-associated membrane protein;
LC3, microtubule-associated protein light chain 3; MA, macroautophagy; ROS, reactive oxygen species.
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INTRODUCTION
Basal levels of autophagy are critical to cellular homeostasis by
eliminating malfunctioning organelles and long-lived proteins
(Levine and Kroemer, 2008). Autophagy increases with nutrient
deprivation and hypoxia (Levine and Kroemer, 2008). Defects
in autophagy impact several diseases, including cancer (Levine
and Kroemer, 2008; Morselli et al., 2009; Choi, 2012). However,
the role of autophagy in cancer development is complex. While
basal autophagy may function as a tumor suppressor, increased
or induced autophagy may contribute to tumor survival during
cancer progression (Morselli et al., 2009; Choi, 2012).
Two forms of autophagy, MA and CMA are detectible in
human cells and upregulated in many tumors (Morselli et al.,
2009; Kon et al., 2011; Choi, 2012). MA increases with cell
nutrient stress and temporally wanes as CMA increases and
is sustained. During nutrient or growth factor deprivation,
MA and CMA are upregulated to promote cell survival
by recycling building blocks, modulating bioenergetics, and
shifting metabolism. During MA, cytoplasmic macromolecules
and organelles are sequestered inside autophagosomes, which
fuse with lysosomes to promote content degradation. Basal
levels of MA may prevent tumor development by modulating
chromosome stability and removing mutated proteins and
damaged mitochondria (Morselli et al., 2009; Choi, 2012).
However, with tumor progression and exposure to metabolic
stresses, MA is induced to recycle nutrients, favor tumor
survival and resistance to anti-cancer therapies (Morselli
et al., 2009; Choi, 2012). During CMA HSC70 and HSP90,
capture cytoplasmic proteins for selective translocation into
lysosomes for degradation (Agarraberes and Dice, 2001). CMA
is upregulated in many tumors including melanoma, breast, and
lung cancers (Kon et al., 2011; Saha, 2012; Zhou et al., 2016).
CMA relies on a LAMP-2A to translocate cytoplasmic proteins
into lysosomes (Cuervo and Dice, 1996). Hyper-expression of
LAMP-2A is observed in tumors, while disrupting LAMP-2A
expression slows tumors growth and metastasis (Kon et al., 2011;
Zhou et al., 2016).
LAMP-2 is a highly glycosylated protein localized in acidic
lysosomal and endosomal compartments. Alternative splicing
generates three isoforms LAMP-2A, LAMP-2B, and LAMP-2C,
which differ primarily in the sequence of their transmembrane
and cytosolic tail (Eskelinen et al., 2005). LAMP-2A and LAMP-
2B are constitutively expressed by all cells, while LAMP-2C has a
much more limited tissue distribution (Perez et al., 2016). LAMP-
2A, the receptor for CMA may modulate aging and tumor growth
(Cuervo and Dice, 1996, 2000; Kon et al., 2011; Perez et al.,
2016). LAMP-2B is involved in lysosome biogenesis and MA
(Nishino et al., 2000). Mutations in LAMP-2B have been reported
to disrupt autophagosome maturation. LAMP-2C can facilitate
DNA and RNA translocation into lysosomes, while enhanced
LAMP-2C expression inhibits CMA in human B lymphoblasts
(Fujiwara et al., 2013a,b; Perez et al., 2016). Yet, little is known
about LAMP-2C function in tumor cell growth and autophagy.
In vivo, tumors such as melanomas encounter infiltrating
immune cells producing pro-inflammatory cytokines, which
can induce stress and limit tumor growth. While melanoma
cells express relatively low levels of LAMP-2C compared to
LAMP-2A and LAMP-2B, as shown here exposure of these
cells to the cytokine IFN-γ significantly increased LAMP2C
mRNA abundance. By contrast, only marginal changes in
LAMP2A mRNA expression and no difference in LAMP2B
mRNA abundance were detected in IFN-γ treated melanoma
cells. These cytokine-induced changes suggested that LAMP-2C
could potentially play a role in regulating tumor cell survival
and responses to stress. In this study, we explored the role
of LAMP-2C in the growth and survival of human melanoma
cells using a rodent xenograft model. Human melanoma cells
were transfected to increase LAMP-2C protein expression. In
the melanoma cell line DM331, ectopic expression of LAMP-
2C resulted in decreased expression of LAMP-2A and LAMP-2B
proteins. CMA was diminished in cells with increased LAMP-
2C, as indicated by the increased abundance of several proteins
typically targeted for degradation by CMA including Chk1,
IκBα, and p21 (Cuervo et al., 1998; Park et al., 2015; Zhang
et al., 2018). Significant reductions in MA were also detected
in melanomas with increased LAMP-2C expression based on
analysis of MA flux and autophagosome abundance. Ectopic
expression of LAMP-2C altered melanoma cell growth in vitro
and cell cycle progression with increased apoptosis and necrosis
detectable in several melanoma cell lines. These changes in the
cell cycle may be related to the greater abundance of Chk1
and phospho-Chk1 as well as p21 in melanomas with increased
LAMP-2C. In vivo, human melanoma cells with increased LAMP-
2C displayed reduced growth and increased necrosis compared
with the parental melanoma cell line. This study demonstrates
a novel role for LAMP-2C in melanoma growth and offers
innovative strategies for targeting subcutaneous melanoma.
MATERIALS AND METHODS
Cell Lines and Transfection
The human melanoma cell line DM331 provided by
Dr. V. Engelhard (University of Virginia) was maintained
in RPMI-1640 with 5% FBS, 50 U/ml penicillin, 50 µg/ml
streptomycin, and 1% L-glutamine (Slingluff et al., 2000). The
human melanoma cell line SLM2-Mel provided by Dr. W. J.
Storkus (University of Pittsburgh School of Medicine) was
maintained in the same media with 0.1% β-mercaptoethanol
(Haque et al., 2002). Melanoma cell lines were transfected using
Xfect Transfection Reagent (Clontech, Mountain View, CA,
United States). Control vectors or vectors encoding human
LAMP2C have been described (Perez et al., 2016).
Reverse Transcription Polymerase Chain
Reaction (RT-PCR)
To detect LAMP2 or GAPDH transcript expression, cellular
RNA was extracted using RNeasy Mini Kit (Qiagen, Valencia,
CA, United States) and cDNA was generated using the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA, United States). Primers for LAMP2 and GAPDH
amplification were described (Perez et al., 2016). LAMP2 cDNA
was amplified using 2X ReddyMix PCR Master Mix (Thermo
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Fisher Scientific, Waltham, MA, United States) for 35 cycles.
GAPDH cDNA was amplified for 30 cycles. PCR products were
resolved by agarose gel.
Real-Time Quantitative PCR (qPCR)
qPCR was performed using custom Taqman primers for
LAMP2A, LAMP2B, and LAMP2C (Perez et al., 2016) or
commercial primers CDKN1A, CHEK1, CTSA, CTSB, CTSD,
NFKBIA, TP53, ACTB, GAPDH or 18S, and the 7500 Fast RT-
PCR System from Applied Biosystems. Gene expression was
normalized to ACTB, GAPDH or 18S mRNA levels and presented
as a relative fold change compared with control samples or
presented as mRNA expression relative to 18S mRNA levels. For
analysis of fold changes in mRNA, if differences of less than
twofold were detected, trends in expression were noted rather
than statistical significance.
Western Blotting
Cells were lysed on ice for 30 min with RIPA buffer, protease
inhibitor cocktail ± phosphatase inhibitor cocktail. Cell lysate
proteins (80 µg) were resolved on SDS-PAGE and transferred
to nitrocellulose for western blots. Blots were quantitated by
densitometry using ImageJ (NIH, Bethesda, MD, United States)
and normalized to cellular actin. Antibodies against LAMP-
2A (Cat #ab18528), LAMP-2B (Cat #ab18529), HSP90 (Cat
#ab13494), and cathepsin A (Cat #ab79590) were from Abcam
(Cambridge, MA, United States). Chk1 (Cat #2360), phospho-
Chk1 (Ser345) (Cat #2341), IκBα (Cat #4814), phospho-IκBα
(Ser32/36) (Cat #9246), LC3B (Cat #2775), and histone H3 (Cat
#3638) were from Cell Signaling Technology (Danvers, MA,
United States). LAMP-2 (Cat #H4B4-c) was from DSHB (Iowa
City, IA, United States) and HSC70 (Cat #ADI-SPA-815) from
Enzo Life Sciences (Farmingdale, NY, United States). Anti-Myc
Tag (Cat #05-724) and cathepsin D (Cat # IM03) were from EMD
Millipore (Billerica, MA, United States). Cathepsin B (Cat # sc-
13985), p53 (Cat # sc-126), and p21 (Cat # sc-756) were from
Santa Cruz Biotechnology (Santa Cruz, CA, United States). Actin
(Cat # MS-1295-P0) was from Thermo Fisher Scientific.
Interferon-Gamma Treatment
DM331 cells were incubated 24 h at 37◦C with 400 or 2000 units
(IU) of recombinant human IFN-γ (R&D Systems, Minneapolis,
MN, United States). Cells were harvested and LAMP2 mRNA was
measured by qPCR.
MA Analysis
To detect MA flux, cells were incubated for 16 h at 37◦C± 20 µM
CQ (Sigma-Aldrich, St. Louis, MO, United States) (Mizushima
and Yoshimori, 2007; Mizushima et al., 2010; Klionsky et al.,
2012). Western blotting was used to detect cellular LC3I and
LC3II. Cellular LC3I and LC3II protein levels were normalized
relative to actin protein levels to account for protein sample
loading. MA flux was determined by subtracting the relative
ratio of LC3II/actin in untreated cells from the relative ratio of
LC3II/actin for CQ treated cells. To monitor MA in real time
within live cells, melanoma cells were incubated 4 h at 37◦C
with media ± serum. Vesicles produced during MA in normal
or starvation conditions were stained using CYTO-ID Autophagy
detection kit (Enzo Life Sciences) and analyzed by flow cytometry
(Guo et al., 2015).
Lysosomal Proteases or Calpain
Inhibition
To detect changes in LAMP-2A protein levels, cells were
incubated 18 h at 37◦C ± 20 µM CQ or 10 µM calpeptin (EMD
Millipore). Samples were resolved on SDS-PAGE and analyzed by
western blotting.
Apoptosis Assay
For detection of apoptotic and necrotic cells, real time analysis
of caspase-3 and caspase-7 activity was detected using CellEvent
Caspase-3/7 Green Flow Cytometry Assay Kit (Invitrogen,
Carlsbad, CA, United States). During apoptosis, caspase-3 and
caspase-7 are activated and able to cleave a cell permeable
fluorogenic substrate DEVD peptide. The bright fluorogenic
signal produced by caspase-3 and caspase-7 activity indicates
apoptotic cells. Cells positive for AAD dead cell stain help
separate live from dead cells. Samples were analyzed by flow
cytometry.
Subcellular Fractionation
Cytoplasmic and nuclear proteins were extracted using NE-PER
Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher
Scientific) following manufacturer’s recommended instructions.
Samples were resolved on SDS-PAGE and analyzed by western
blotting.
Cell Cycle Analysis
Cells were fixed with 70% cold ethanol (−20◦C) for 1 h at
4◦C, washed with ice-cold PBS, incubated 15 min at 37◦C with
100 µg/ml RNase A (Sigma-Aldrich), and then stained 30 min at
room temperature with 50 µg/ml of propidium iodide (Sigma-
Aldrich). Samples were analyzed by flow cytometry.
[3H] Thymidine Incorporation
Cells were incubated with [3H] thymidine for 8 h at 37◦C.
Thymidine incorporation was quantified using Wallac 1450
Microbeta Plus liquid scintillation counter (Perkin Elmer,
Shelton, CT, United States).
Reactive Oxygen Species Analysis
Basal ROS were measured by incubating cells with 5µM CellROX
Deep Red Reagent (Thermo Fisher Scientific, Waltham, MA,
United States) for 30 min at 37◦C. This cell-permeant dye is
non-fluorescent while in a reduced state, and fluoresces upon
oxidation by ROS. Samples were analyzed by flow cytometry.
Proteasome Assay
Proteasome activity was determined using Proteasome-Glo
Chymotrypsin-Like Cell-Based Assay (Promega, Madison, WI,
United States) (Moravec et al., 2009). Cells were trypsinized
and plated according to the manufacturer’s recommended
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instructions. Cells were incubated with Proteaseome-Glo
Cell Based Reagent to deliver the substrate (Succinyl-LLVY-
aminoluciferin) into the cytoplasm of the cells. Aminoluciferin,
which is the substrate for luciferase, is released following
cleavage of this peptide substrate by the proteasome. Luciferase
consumption of aminoluciferin results in a luminescent
signal that is proportional to the amount of proteasome
activity (Moravec et al., 2009). Luminescence was detected
using SpectraMax M5 Microplate Reader (Molecular Devices,
Sunnyvale, CA, United States). Studies have indicated the
specificity of this assay in multiple cultured cell lines in detecting
changes in proteasome activity (Moravec et al., 2009).
Xenograft Studies
Female NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ mice 6–8 weeks of age
were obtained from the In Vivo Therapeutics Core of the Indiana
University and injected in the flanks with 5× 105 melanoma cells.
Animals were monitored two to three times a week following
tumor implantation to detect changes in health and weight.
Tumor size was measured biweekly as length (mm) × width
(mm) × width (mm)/2 to obtain a measure of volume in
mm cubed. All animals were terminated 20 days after tumor
implantation, and tissues and palpable tumors were collected for
analysis.
Ethics Statement
Mice were maintained in specific pathogen-free conditions under
conditions approved by the Institutional Animal Care and Use
Committee of Indiana University School of Medicine and the
Guide for the Care and Use of Laboratory Animals.
Tissue Processing and Staining
Tissues were fixed in 10% neutral-buffered formalin at 4◦C
for 24 h followed by processing and paraffin embedding. Five-
micrometer sections were cut and stained for hematoxylin
and eosin (HE) or phospho-Histone H3 (EMD Millipore,
Cat #06-570).
Assessment of Necrosis and
Phospho-Histone H3 (pH3) Positivity
The Aperio ScanScope CS system whole slide digital
imaging system (Leica Biosystems, Buffalo Grove, IL,
United States) was used for imaging slides at 20X.
Necrosis was determined by quantifying cells with nuclear
fragmentation in randomly selected fields of primary tumors.
As a measure of mitosis, five hot spots were selected per
slide and cells positive for pH3 staining were quantified
using the Positive Pixel Count V9 algorithm of Aperio
ImageScope software (Leica Biosystems, Buffalo Grove, IL,
United States). pH3 positivity represents pH3 positively stained
cells divided by the total number of cells in the selected
areas.
Statistical Analysis
Data were analyzed by two-way ANOVA or by two-tailed,
unpaired Student’s t-test using GraphPad Prism 6.0 (GraphPad
Software, San Diego, CA, United States). A value of p < 0.05
or less was considered significant for all experiments. Error bars
indicate SD unless noted otherwise.
RESULTS
Expression of LAMP-2C in Human
Melanoma Cells
Therapeutic treatment of many cancers including melanoma with
IFN-γ, is well documented (Zaidi and Merlino, 2011). IFN-γ
negatively impacts tumor growth and alters the expression of
multiple genes (Zaidi and Merlino, 2011). Exposure of tumors
to IFN-γ can induce cell stress marked in some cases by
increased cellular ROS production, upregulation of the DNA
damage response, as well as enhanced cell senescence and death
(Hubackova et al., 2016). Prior work had shown that exposure
to toll-like receptor ligands, immune mediators often associated
with infection, alters LAMP2 isoforms mRNA expression in
human B lymphoblasts (Perez et al., 2016). To address whether
differential regulation of LAMP2 isoforms is observed in human
melanomas, we exposed melanoma cells to IFN-γ. A twofold
to threefold induction of LAMP2C mRNA was observed upon
melanoma cells exposure to IFN-γ with very modest changes
in the more abundant LAMP2A and no induction of LAMP2B
(Figure 1A). These results suggest that LAMP2C expression can
be upregulated by cytokine stress in human melanomas.
The hierarchy of endogenous LAMP2 mRNA expression
(LAMP2B > LAMP2A > LAMP2C) was consistent among
two distinct human melanoma cell lines, DM331 and SLM2-
Mel (Figures 1B,C). Given the low basal levels of LAMP2C
mRNA in each melanoma cell line, this isoform was ectopically
expressed in each cell line to examine its impact on autophagy,
cell growth and survival (Figure 2). LAMP-2 isoforms can be
detected using commercial antibodies that recognize conserved
epitopes, but individual isoform analysis can be challenging
given their structural homology. To circumvent the absence of
antibodies against LAMP-2C, melanoma cells (DM331 or SLM2-
Mel) were transfected with a plasmid encoding C-terminal myc
tagged LAMP2C yielding DM331 2C myc or SLM2-Mel 2C myc
cells (Figures 2A,B). As a control, the parental cell lines were
transfected with an empty vector to produce DM331 pCMV
or SLM2-Mel pCMV cells (Figures 2A,B). As an additional
control, DM331 cells were also transfected with a distinct
empty vector (DM331 zeo) or a plasmid encoding untagged
LAMP2C (DM331 2C) to ensure the myc tag was not impacting
function (Figure 2C). Increased LAMP2C mRNA was detected in
melanoma cells transfected with the LAMP2C plasmid (Figure 2).
Higher levels of ectopic LAMP2C mRNA were detected in
DM331 cells compared to the SLM2-Mel cells, regardless of myc
tag addition (Figure 2). While there was no significant change
in LAMP2A mRNA levels with ectopic LAMP-2C expression in
cells, a slight reduction was observed in mRNA levels of LAMP2B
(Figure 2).
Western blot analysis of melanoma cells revealed similar
electrophoretic migration of ectopic LAMP-2C and other LAMP-
2 isoforms on SDS-PAGE (Figures 2B,C, 3). LAMP-2 isoforms
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FIGURE 1 | LAMP2 expression in melanomas during IFN-γ treatment. (A) DM331 cells treated for 24 h with 400 or 2000 IU of IFN-γ. Gene expression of LAMP2A,
LAMP2B, and LAMP2C were analyzed by qPCR. mRNA levels were normalized to ACTB expression with the expression of each isoform set equal to one for control
cells without cytokine exposure. (B) Endogenous mRNA levels of LAMP2 isoforms in DM331 cells were quantitated relative to 18S mRNA levels. (C) Endogenous
mRNA levels of LAMP2 isoforms in SLM2-Mel cells. Gene expression was quantitated relative to 18S mRNA levels. Data were analyzed by two-way ANOVA.
∗∗∗∗p < 0.0001 (n = 3).
FIGURE 2 | LAMP-2 expression in human melanoma cell lines transfected with LAMP-2C. (A) DM331 cells were transfected with an empty vector (pCMV) or a
plasmid encoding for C-terminal myc tagged LAMP2C. RT-PCR analysis for LAMP2C overexpression was detected in an agarose gel. mRNA levels of LAMP2A,
LAMP2B, and LAMP2C transcripts were analyzed by qPCR and normalized to 18S expression. To detect relative changes in the expression of each isoform, the
normalized expression of each isoform was set equal to one in DM331 pCMV cells. (B) SLM2-Mel cells were transfected with an empty vector (pCMV) or a plasmid
encoding for C-terminal myc tagged LAMP2C. mRNA levels of LAMP2A, LAMP2B, and LAMP2C in these cells were analyzed by qPCR and normalized to ACTB
expression. The relative expression of each isoform was set equal to one for SLM2-Mel pCMV control cells. Cell lysates were probed for the c-myc tagged LAMP2C
or total LAMP2 protein with actin used as a control for sample loading. Arrow indicates non-specific protein band detected with anti-myc antibody. (C) DM331 cells
were transfected with an empty vector (zeo) or a plasmid encoding for LAMP2C with no tag sequence. mRNA levels of LAMP2A, LAMP2B, and LAMP2C in these
cells were analyzed by qPCR and normalized to GAPDH expression. To examine relative changes in each isoform, the expression of individual isoforms was set to
one for the DM331 zeo control cells. Cell lysates were probed for total LAMP2 protein with actin used as a control for sample loading. Data were analyzed by
two-way ANOVA or by two-tailed, unpaired Student’s t-test. ∗∗∗∗p < 0.0001 (n = 2–3).
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FIGURE 3 | LAMP-2C ectopic expression in melanoma cells altered LAMP-2A and LAMP-2B protein expression. LAMP-2C myc, total LAMP-2, LAMP-2A,
LAMP-2B, HSC70, HSP90, and actin were detected in DM331 pCMV and DM331 2C myc cells. The normalized expression of each protein was set equal to one for
DM331 pCMV cells for relative comparison with protein levels in DM331 2C myc cells. Data were analyzed by two-tailed, unpaired Student’s t-test. ∗p < 0.05 and
∗∗∗p < 0.001 (n = 3).
are translated as polypeptides of approximately 42 kDa, with
glycosylation of these isoforms yielding proteins which migrate
as diffuse bands on SDS-PAGE with an apparent molecular mass
of 120 kDa. The diffuse appearance and similar electrophoretic
migration of LAMP-2C ectopically expressed with or without
a myc tag in melanomas, was consistent with a high degree of
glycosylation observed with other LAMP-2 isoforms. Cellular
levels of total LAMP-2, detected with an antibody recognizing
all isoforms, were increased 1.5- to 4-fold in melanoma cells
likely due to the increase in LAMP2C mRNA (Figures 2B,C, 3).
Notably, the expression of both LAMP-2A and LAMP-2B
proteins was reduced about 50% in cells with increased LAMP-
2C (Figure 3). Cellular levels of CMA chaperones HSC70 and
HSP90 were unperturbed by increased LAMP-2C (Figure 3).
These findings suggest that increased LAMP-2C expression in
melanoma cells may affect cellular levels of LAMP-2A and
LAMP-2B proteins.
Tumors have been manipulated using molecular approaches
to reduce constitutive LAMP2A mRNA expression to impact
cell growth (Kon et al., 2011; Saha, 2012; Zhou et al., 2016).
Here, the reduction in LAMP-2A protein abundance with ectopic
LAMP-2C expression suggested post-translational regulation of
this isoform’s expression. A lysosomal serine protease cathepsin
A and a cytoplasmic cysteine protease calpain I regulate LAMP-
2A protein stability and turnover (Cuervo et al., 2003; Villalpando
Rodriguez and Torriglia, 2013). To examine whether melanoma
cell LAMP-2C expression impacts proteolytic turnover of LAMP-
2A, DM331 2C myc cells were incubated with CQ, a weak base
which prevents cathepsin A activation in acidic organelles, or
with calpeptin, a cell permeable calpain inhibitor. The addition
of these agents to control DM331 pCMV cells, with low
endogenous LAMP-2C, slightly increased steady state LAMP-
2A protein abundance (Figures 4A,B). Yet in melanoma cells
with high LAMP-2C expression, treatment with these inhibitors
unexpectedly promoted an even greater reduction in cellular
LAMP-2A protein levels. CQ treatment neutralizes lysosome,
endosome, and autophagosome pH, reducing the activity of
multiple enzymes including proteases functional at low pH.
We examined several lysosomal cathepsins to determine if
LAMP-2C expression increased the abundance and maturation
of these enzymes to active proteases, possibly explaining the
observed decrease in melanoma cell levels of LAMP-2A protein
with ectopic LAMP-2C expression. Cellular levels of mature
and precursor forms of lysosomal proteases cathepsin A and
cathepsin B were unchanged in melanoma cells by ectopic
LAMP-2C. Expression of the mature cathepsin D (30 kDa)
protein was also not statistically different with ectopic LAMP-
2C expression in cells, while cathepsin D immature precursors
(46 kDa and 52 kDa forms) were significantly decreased in
cells with high LAMP-2C expression (Figure 4C). The 30 kDa
and 46 kDa forms of cathepsin D are functional aspartyl
proteases. Quantitative analysis of transcripts for cathepsin
genes CTSA, CTSB, and CTSD corroborated that ectopic
expression of LAMP-2C in melanoma cells did not increase
the expression of these lysosomal enzyme mRNAs (Figure 4C).
Rather a slight decrease in CTSA and CTSD mRNA was
detected in cells with ectopic LAMP-2C. Thus, the decreased
abundance of LAMP-2A observed in melanoma cells with high
LAMP-2C expression, was not linked to an increased cellular
accumulation of these three cathepsin proteases. Together, these
results suggest increased LAMP-2C expression in melanoma
cells perturbs steady state levels of LAMP-2A and LAMP-2B,
each of which has been implicated in regulating autophagy
pathways.
LAMP-2C Expression Impacts CMA
and MA
Impaired CMA can alter intracellular accumulation of select
cytoplasmic proteins targeted for degradation by this pathway.
Steady state levels of two well-described CMA protein substrates,
the cell cycle regulator Chk1 and the inhibitor of NF-κB signaling
pathway IκBα, were examined in melanoma cells with ectopic
LAMP-2C expression (Cuervo et al., 1998; Park et al., 2015).
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FIGURE 4 | Changes in LAMP-2A protein expression were not due to increased cathepsin or calpain abundance in melanomas expressing LAMP-2C. DM331
pCMV and DM331 2C myc cells were incubated overnight at 37◦C with ±20 µM CQ (A) or 10 µM calpeptin (calp) (B) to inhibit lysosome proteases or calpain
activity, respectively. LAMP-2A levels were detected by western blotting, evaluated by densitometry, and normalized to actin protein levels. LAMP-2A levels were
calculated relative to DM331 pCMV cells cultured without CQ or calpeptin. (C) Maturation and gene expression of lysosome proteases cathepsin A (CTSA),
cathepsin B (CTSB), and cathepsin D (CTSD) was evaluated in cells overexpressing LAMP-2C. Lysates were resolved by SDS-PAGE and probed to detect the
precursor (p), intermediate (i), or mature (m) form of cathepsin A, cathepsin B, and cathepsin D. Protein expression was quantified by densitometry and levels were
normalized to actin levels. mRNA levels of CTSA, CTSB, and CTSD transcripts were analyzed by qPCR and normalized to 18S expression. Measurements in (A–C)
are relative values calculated by setting the results obtained for DM331 pCMV cells equal to one for comparison to DM331 2C myc cells. Data were analyzed by
two-way ANOVA. ∗∗p < 0.01, and ∗∗∗p < 0.001 (n = 3).
Elevated levels of Chk1 and total or phosphorylated IκBα
were observed in DM331 2C myc melanoma cells, suggesting
disruptions in the proteolytic turnover of these proteins via CMA
(Figure 5A). Increased cellular expression of Chk1 and IκBα
was not due to higher CHEK1 and NFKBIA mRNA transcripts,
again consistent with CMA disruption in melanoma cells with
high LAMP-2C expression (Figure 5B). Changes in autophagy
can impact cytoplasmic protein degradation by the proteasome
(Park and Cuervo, 2013). CMA substrates Chk1 and IκBα can
be diverted to the proteasome in some cell types (Alkalay et al.,
1995; Zhang et al., 2005). We quantitated proteasome proteolytic
activity in DM331 2C myc cells using a specific proteasome
substrate, succinyl-LLVY-aminoluciferin, delivered selectively
into the cytoplasm of melanoma cells. Proteasome activity was
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FIGURE 5 | Effect of LAMP-2C expression on CMA substrates. (A) Cellular levels of CMA substrates Chk1, IκBα, and p-IκBα in DM331 pCMV and DM331 2C myc
cells were examined by western blotting. Relative protein levels were calculated by setting the normalized expression to one for DM331 pCMV cells. (B) mRNA levels
of CHEK1 and NFKBIA transcripts were analyzed by qPCR and normalized to ACTB expression. mRNA levels in DM331 pCMV cells were normalized and set to
one. (C) Proteasome activity was measured using the Proteasome-Glo Chymotrypsin-Like Cell-Based Assay. Cells were incubated with a substrate
succinyl-LLVY-aminoluciferin which penetrates into the cytoplasm. This substrate is cleaved by the proteasome to release aminoluciferin which is released from cells.
Luciferase is added to these cells, cleaving aminoluciferin to a luminescent product detectable using a luminometer. Data were analyzed by two-way ANOVA or by
two-tailed, unpaired Student’s t-test. ∗p < 0.05, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 (n = 3).
not reduced in cells with ectopic LAMP-2C expression but rather
slightly increased compared to control cells (Figure 5C). These
data suggest that LAMP-2C myc expression in melanoma cells
disrupts CMA and increased cellular protein levels of several
CMA substrates.
LAMP-2B is required for efficient cellular MA, thus changes in
MA were examined in melanoma cells with increased LAMP-2C
(Nishino et al., 2000). The intracellular abundance and stability of
LC3 I and II are used to monitor MA (Mizushima and Yoshimori,
2007; Mizushima et al., 2010; Klionsky et al., 2012). During MA,
cytoplasmic LC3I is lipidated, and converted to LC3II, which
associates with autophagosomes. LC3II is then proteolyzed upon
autophagosome maturation marking a full cycle of MA. An
accurate measure of this autophagy pathway can be obtained
through analysis of MA progression or flux (Klionsky et al., 2012).
Changes in LC3I and LC3II protein levels were detected in each
of the melanoma cells with ectopic LAMP-2C in the presence
or absence of CQ, the latter which neutralizes autophagosome
acidification to slow LC3II degradation during MA. Monitoring
the relative LC3II (LC3II/actin) levels in cells treated with CQ
and subtracting the relative LC3II (LC3II/actin) abundance in
cells without CQ, offers a measure of MA progression or flux
(Klionsky et al., 2012). MA flux was diminished in DM331 cells
with increased LAMP-2C myc (Figure 6A). Decreased MA flux
was observed in DM331 cells expressing untagged LAMP-2C
and a distinct cell line, SLM2-Mel 2C myc (Figures 6B,C).
Consistent with the flux analysis suggesting disruptions in
MA in melanoma cells with ectopic LAMP-2C, the relative
levels of LC3I (basal LC3I/actin) were increased in untreated
melanoma cells. While relative LC3I abundance in cells does not
measure MA, the detected accumulation of LC3I may suggest
a slowing or disruption in early stages of MA in the context of
reduced flux. As an alternate approach to evaluate cellular MA
in these melanoma cells, DM331 2C myc were treated with a dye
CYTO-ID that fluoresces upon delivery into autophagosomes.
Cellular stresses, such as nutrient starvation, promote an increase
in CYTO-ID accumulation in newly forming autophagosomes
(Guo et al., 2015). DM331 pCMV and DM331 2C myc cells
were incubated ± serum and autophagosomes stained using
CYTO-ID to evaluate MA. MA was reduced in melanoma
cells with LAMP-2C cultured in serum as detected by flow
cytometry (Figure 6D). Reductions in MA were apparent in
serum nutrient starved DM331 cells with increased LAMP-2C
expression compared to control cells (Figure 6D). Tumor cells
may encounter a variety of stresses in vivo including limitations
in nutrient availability, oxygen deficiency, and inflammatory
mediators. Experiments here suggest that ectopic LAMP-2C
expression in melanoma cells reduces MA under basal and stress
conditions. Thus, increased LAMP-2C expression in melanoma
cells results in disruptions in cellular MA.
Ectopic LAMP-2C Expression Perturbs
Cell Cycle and Survival
Autophagy pathways control a variety of cellular processes
and have been linked to cell cycle regulation and survival
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FIGURE 6 | MA was diminished in melanomas with increased LAMP-2C. (A–C) DM331 or SLM2-Mel cells were incubated overnight with ±20 µM CQ, an inhibitor
of lysosome acidification, to monitor autophagosome formation and turnover. To measure MA flux, the conversion of LC3I to LC3II was detected and normalized to
cellular actin levels. MA flux was quantified to detect changes in cellular LC3II levels ± CQ using the equation MA flux = LC3II/actin in CQ treated cells – LC3II/actin
in control cells. The relative levels of LC3I/actin in each cell line grown without CQ provides a measure of basal LC3I protein accumulation prior to its enzymatic
conversion to LC3II during MA. (D) DM331 pCMV and DM331 2C myc cells were incubated with media ± serum, stained with CYTO-ID, and MA monitored by flow
cytometry. The geometric mean was set equal to one for DM331 pCMV cells for relative comparison to the geometric mean in DM331 2C myc cells. Data were
analyzed by two-way ANOVA or by two-tailed, unpaired Student’s t-test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 (n = 3).
(Levine and Kroemer, 2008). Previous reports have shown
alterations in cell proliferation and apoptosis of distinct tumors
after blocking CMA by LAMP-2A silencing (Kon et al., 2011;
Saha, 2012; Zhou et al., 2016). Given LAMP-2A protein levels
were reduced in melanoma cells expressing LAMP-2C, this
led us to question whether cell proliferation or apoptosis
was perturbed in these cells. DM331 2C myc cells exhibited
alterations in the cell cycle distribution as monitored by flow
cytometric analysis of cellular DNA content (Figure 7A). While
the percentage of melanoma cells in G0/G1 phase decreased with
ectopic LAMP-2C expression, an increase was detected in the
percentage of these cells in G2/M phase (Figure 7B). A reduction
in thymidine incorporation by DM331 2C myc cells was also
detected compared to this cell transfected with vector alone
(Figure 7B). Similarly, fewer DM331 cells expressing untagged
LAMP-2C and SLM2-Mel 2C myc cells were at the G0/G1 stage,
with these melanoma cells displaying more G2/M phase cells
(Figure 7C). While differences in cell distributions in S phase
were observed with altered LAMP-2C expression, these changes
were variable among the different melanoma cells. These data
suggest that LAMP-2C expression in these melanoma cells may
disturb cell division via cell cycle arrest. To complement these
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FIGURE 7 | Reduced survival and altered cell cycle in melanomas expressing LAMP-2C. (A) Apoptosis and necrosis were examined by incubating DM331 pCMV
and DM331 2C myc cells with a fluorogenic substrate specific for activated caspase-3 and caspase-7 in apoptotic cells and AAD dead cell stain to detect necrotic
cells. Apoptotic and necrotic cells were detected by flow cytometry. (B) Representative dot plot graph of the cell cycle distribution of DM331 pCMV and DM331 2C
myc cells. Cell cycle distribution was evaluated by staining DNA content of DM331 pCMV and DM331 2C myc cells with propidium iodide and quantified by flow
cytometry. (C) Cell cycle distribution of DM331 zeo and DM331 2C was evaluated by staining DNA content with propidium iodide and quantified by flow cytometry.
(D) Cell cycle distribution was analyzed by staining the DNA content of SLM2-Mel pCMV and SLM2-Mel 2C myc with propidium iodide and detected by flow
cytometry. (E) To examine basal ROS production, melanomas with and without ectopic LAMP-2C expression were incubated for 30 min at 37◦C with 5 µM CellROX
Deep Red Reagent and monitored by flow cytometry. Data were analyzed by two-way ANOVA or by two-tailed, unpaired Student’s t-test. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 (n = 2–3).
studies, an analysis of melanoma cell death and necrosis was
carried out using melanoma cells with and without ectopic
LAMP-2C expression. Levels of apoptosis and/or necrosis were
increased in each melanoma cell line with ectopic LAMP-2C
expression compared to cells transfected with vector alone
(Figure 7D). ROS generated by tumor cells can impact cellular
autophagy pathways and growth (Poillet-Perez et al., 2015).
ROS production was evaluated in melanoma cells with ectopic
LAMP-2C and compared to the control melanoma cells with
vector alone. There was no consistent increase or decrease in
cellular ROS among the three pairs of tumor cell lines tested.
Although a slight increase in ROS production was detected with
DM331 2C myc cells compared to vector transfected cells, and
a reduction in ROS production was observed for SLM2-Mel 2C
myc cells compared to the vector transfected cells (Figure 7E).
These results suggest that increased LAMP-2C expression
in melanoma cells perturbs cell cycle progression as well as
apoptosis and necrosis.
Chaperone-mediated autophagy substrate Chk1, a key
regulator during DNA replication and DNA damage responses,
contributes to all cell cycle checkpoints, including G1/S,
intra-S-phase, G2/M, and the mitotic spindle checkpoint
(Patil et al., 2013). In response to genotoxic stress, Chk1
is phosphorylated and activates DNA damage responses to
bring about cell cycle arrest, activate DNA repair pathways,
and induce apoptosis when DNA damage is severe (Patil
et al., 2013). Chk1 Ser345 phosphorylation is critical for this
activation and function in response to DNA damage (Patil
et al., 2013; Goto et al., 2015). Higher cellular levels of Chk1
Ser345 phosphorylation were detected in DM331 2C myc
cells compared to control cells, suggesting increased activation
of Chk1 in melanoma cells with high LAMP-2C expression
(Figure 8A). Although Chk1 is mainly expressed in the nucleus,
following activation Chk1 shuttles between the nucleus and
cytoplasm (Patil et al., 2013; Goto et al., 2015). Consistent with
the increased phosphorylation of Chk1 in cells with ectopic
Frontiers in Cell and Developmental Biology | www.frontiersin.org 10 August 2018 | Volume 6 | Article 101
fcell-06-00101 August 27, 2018 Time: 19:47 # 11
Pérez et al. LAMP-2C Alters Autophagy in Melanoma
FIGURE 8 | Effect of LAMP-2C on cell cycle regulators. (A) Chk1 activation was examined by detecting cellular levels of Chk1 phosphorylation at Ser345. (B) Chk1
subcellular localization was determined by extracting cytoplasmic and nuclear proteins from DM331 pCMV and DM331 2C myc cells. Protein levels were detected
by western blotting. (C) Protein and mRNA levels of cell cycle regulators in DM331 pCMV and DM331 2C myc, p53 and p21, were examined by western blotting
and qPCR. (D) Lysates from DM331 zeo and DM331 2C were resolved by SDS-PAGE and probed to detect p21 levels. Protein expression was quantified by
densitometry and levels were normalized to actin levels. (E) Protein levels of p21 in SLM2-Mel pCMV and SLM2-Mel 2C myc were detected by western blotting.
Protein expression was quantified by densitometry and levels were normalized to actin levels. Measurements in (A–E) represent relative values calculated by setting
the results obtained for cells transfected with an empty vector equal to one for comparison to cells with ectopic LAMP-2C. Data were analyzed by two-way ANOVA
or by two-tailed, unpaired Student’s t-test. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 (n = 3).
LAMP-2C, slightly more Chk1 protein was detected in the
cytoplasm of these cells (Figure 8B). The tumor suppressor
protein p53 and the cyclin-dependent kinase inhibitor p21
play important roles in G1 and G2 checkpoints (Giono and
Manfredi, 2006; Karimian et al., 2016). Furthermore, increased
cellular levels of p53 and p21 have been observed in cancer
cells with LAMP-2A downregulation (Kon et al., 2011; Zhou
et al., 2016). While p53 protein levels were slightly increased
compared to control melanoma cells, cellular levels of p21 were
markedly increased in DM331 cells with increased LAMP-
2C expression (Figure 8C). Protein levels of p21 were also
increased in DM331 cells expressing untagged LAMP-2C and
SLM2-Mel 2C myc cells (Figures 8D,E). Changes in cellular
levels of p53 and p21 were not a direct result of altered levels
of p53 and p21 mRNA transcripts in DM331 cells with ectopic
LAMP-2C myc expression (Figure 8C). Thus, enhanced LAMP-
2C expression induces cell cycle arrest and affects survival
by altering the abundance and activation of key cell cycle
regulators.
LAMP-2C Expression Reduces
Melanoma Cells Tumorigenic Potential
LAMP-2A knockdown in cancerous cells has been documented to
reduce tumorigenic capability and metastatic capacity (Kon et al.,
2011; Zhou et al., 2016). Given that in vitro studies here showed
changes in the cell cycle of melanoma cells, the tumorigenicity
of melanoma cells with enhanced LAMP-2C expression was
examined in vivo. Previous reports have demonstrated NOD.Cg-
PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mouse model provide an excellent
in vivo system to assess human melanoma metastasis without
the complication of host immune responses to tumor (Quintana
et al., 2012). Here, NSG mice were injected in the flanks with
DM331 cells with or without ectopic LAMP-2C myc, and animals
monitored for tumor growth followed by sacrifice 20 days post
tumor implant. Subcutaneous xenografts growth was reduced
for tumors with high LAMP-2C myc (Figure 9A). Histology of
primary tumors established differences in anatomy (Figure 9B).
While melanoma cells from control tumor were spindle-shaped,
the LAMP-2C myc tumor cells were epithelial-shaped and loosely
joined together (Figure 9B). In addition, HE staining revealed
necrotic areas in LAMP-2C myc tumors were three times greater
than control tumors (Figure 9C). To examine tumor cell mitosis,
tissue sections from palpable tumors where stained to detect
phospho-Histone H3 (Figure 9D). While differences in cell
density were again observed in comparing tumors with ectopic
LAMP-2C or vector alone, no significant difference was detected
in phospho-Histone H3 staining. Together these results revealed
a novel role for LAMP-2C in diminishing melanoma growth
in vivo.
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FIGURE 9 | Ectopic expression of LAMP-2C decreased tumor growth in a xenograft mouse model. NSG mice were implanted subcutaneously in the flanks with
5 × 105 DM331 cells with or without ectopic LAMP-2C myc expression. (A) Tumor growth was monitored biweekly (n = 13 per group). (B) Representative HE
staining of primary control tumor or primary tumor with high ectopic expression of LAMP-2C myc. (C) Percentage of necrotic areas of primary tumors were evaluated
by HE staining (n = 5 per group). (D) Representative pH3 staining of primary tumor with or without LAMP-2C myc expression. To determine changes in mitosis, pH3
positive cells were quantified in five hot spots areas of primary tumors. pH3 positivity was quantified dividing the number of pH3 positively stained cells by the total
number of cells in the selected areas (n = 6 per group). Data were analyzed by two-way ANOVA or by two-tailed, unpaired Student’s t-test. Error bars indicate
mean ± SEM. ∗∗p < 0.01 and ∗∗∗∗p < 0.0001.
DISCUSSION
Deregulation of autophagy pathways has been associated
with melanoma development and progression. While
immunochemistry of normal human melanocytes revealed
low expression of LC3 protein, a histological MA marker, focal
staining of LC3 molecules increased in spreading subcutaneous
melanoma consistent with increased tumor MA (Checinska and
Soengas, 2011; Corazzari et al., 2013). Immunohistochemical
analysis of early and late stage melanomas revealed that late stage
tumors associated with poor prognosis, expressed reduced levels
of p62, a protein whose turnover is linked to enhanced MA (Ellis
et al., 2014). High levels of LAMP-2A, a marker for CMA were
detected in human melanoma biopsies compared with healthy
skin, and reductions in LAMP-2A expression slowed murine
melanoma growth in vitro (Kon et al., 2011). Such results suggest
that pathways or proteins linked to autophagy may influence
melanoma cell growth and tumor progression.
Here, studies examined the role of a lysosomal membrane
protein, LAMP-2C in modulating autophagy as well as cell
cycle and growth in several human melanoma cell lines. LAMP-
2C is highly homologous to LAMP-2A and LAMP-2B, which
regulate CMA and MA respectively (Eskelinen et al., 2005).
While the three LAMP-2 isoforms are derived from a common
precursor mRNA, differential expression of these isoforms has
been observed. LAMP-2A expression levels and basal CMA
activity were increased in a variety of human solid tumors,
including melanoma, lung, breast, and gastric cancers (Kon
et al., 2011; Saha, 2012; Zhou et al., 2016). Inhibition of the
proteasome or MA, has been reported to increase LAMP-2A
expression in neural cells (Yang et al., 2013). In contrast with
LAMP2A and LAMP2B mRNA which are broadly expressed
in different tissues, LAMP2C mRNA has a more limited tissue
distribution (Perez et al., 2016). The mRNA for all three LAMP2
isoforms increased in B lymphoblasts exposed to toll receptor
ligands, which are associated with microbial infection (Perez
et al., 2016). In the current study, treatment of melanoma
cells with the pro-inflammatory cytokine IFN-γ significantly
increased LAMP2C mRNA abundance with only marginal or no
change in LAMP2A and LAMP2B mRNA. This may be due to
an initial increase in the abundance of the LAMP2 precursor
mRNA with selective regulation of mRNA splicing or preferential
mRNA stabilization to yield increased LAMP2C mRNA. The
results with interferon-treated cells are also consistent with tissue
or cell type specific differences in LAMP-2 isoform expression.
The molecular mechanisms which control the expression of
individual LAMP2 mRNAs have not been well examined. As
discussed below, post-transcriptional events can also regulate
LAMP-2 protein expression and function.
Ectopic expression of LAMP-2C in melanomas disrupted
CMA, as indicated by the accumulation of several proteins
typically degraded by CMA including Chk1, IκBα, and p21
(Cuervo et al., 1998; Park et al., 2015; Zhang et al., 2018).
Studies have described an intricate cross-communication and
compensatory mechanisms among the different autophagic
pathways and the proteasome (Park and Cuervo, 2013).
Furthermore, several CMA protein substrates, including Chk1
and IκBα, can also be targeted for proteasome degradation in
some cell types (Alkalay et al., 1995; Zhang et al., 2005). The
current study examined whether cellular proteasome activity
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was decreased with increased LAMP-2C expression in tumors.
Proteasome activity analysis revealed a slight increase in the
activity of this enzyme in melanoma cells with increased
LAMP-2C compared to control cells. Thus, it does not appear
that increasing melanoma cell LAMP-2C expression, disrupts
proteasome function. These findings are also consistent with
previous reports demonstrating upregulation of proteasome
activity in cancer cells with compromised CMA (Kon et al.,
2011). Decreased LAMP-2A and LAMP-2B protein levels
were observed in melanoma cells with ectopic LAMP-2C
expression in the current study. Work by others has shown that
reductions in cellular LAMP-2A levels blocks CMA and promotes
accumulation of CMA substrates (Zhou et al., 2005, 2016; Kon
et al., 2011). Levels of LAMP2A mRNA were unchanged in
melanoma cells with ectopic LAMP-2C, suggesting alterations in
post-transcriptional regulation of LAMP-2A molecules. Studies
of several lysosomal and cytoplasmic proteases known to
function in the turnover of LAMP-2A, failed to reveal a clear
change in these enzymes that might account for the reduction in
cellular LAMP-2A. Instead, attempts to stabilize LAMP-2A using
protease inhibitors in cells with ectopic LAMP-2C, resulted in
greater reductions in LAMP-2A abundance. While not previously
linked to LAMP-2 stability, proteasome activity did increase
in melanomas with ectopic LAMP-2C. LAMP-2A molecules
also form oligomers in lysosomes which regulate CMA, and
it is possible that increased LAMP-2C expression may perturb
oligomer formation. Attempts to detect a physical association
between LAMP-2A and LAMP-2C in melanoma cells, have
not been successful to date. Post-translational modifications of
LAMP-2 isoforms including glycosylation and phosphorylation
have been reported (Tan et al., 2016; Li et al., 2017), and such
modifications could be altered in cells with high levels of LAMP-
2C. The SDS-PAGE mobility of LAMP-2A protein from cells with
or without ectopic LAMP-2C was similar. Further studies will
be necessary to examine the mechanisms influencing LAMP-2A
protein abundance and structure in melanomas with increased
LAMP-2C.
Increased expression of LAMP-2C in human melanomas
also disrupted basal levels of MA as assessed by reduced
autophagic flux and autophagosome abundance. Shifts in
cancer cell metabolism coupled with changes in the tumor
microenvironment can lead to increased hypoxia, nutrient and
growth factor deprivation which induce MA (Morselli et al., 2009;
Choi, 2012). Melanomas with increased LAMP-2C expression
displayed reduced MA induction compared to control cells
in response to serum starvation, a form of nutrient stress
which typically upregulates MA in tumors to promote survival.
As indicated, ectopic expression of LAMP-2C in melanomas
reduced cellular levels of LAMP-2B protein with very modest
decreases in LAMP2B mRNA. Little is known regarding the
stability, post-translational modification, or turnover of LAMP-
2B. Mutations in LAMP-2B were found in patients with
Danon disease and associated with disruptions in MA flux
(Crotzer et al., 2010). Results in the current study suggest that
manipulating melanoma LAMP-2C expression may offer a novel
means to disrupt basal and induced MA as well as CMA in
melanomas.
A common feature in many human cancers is disruption of
target genes involved in cell cycle progression and apoptosis.
Lung and gastric cancer cells with compromised CMA activity
exhibited increased levels of cell senescence regulators, such as
p53 and p21 (Kon et al., 2011; Zhou et al., 2016). While reduced
cell proliferation in lung cancer cells was not linked to cell cycle
arrest, gastric cells with LAMP-2A knockdown displayed cell
cycle arrest (Kon et al., 2011; Zhou et al., 2016). For murine
LAMP-2A deficient fibroblasts cell cycling appeared unchanged,
yet inducing DNA damage in these cells with etoposide or
irradiation increased the percentage of cells in G1 and G2 while
reducing cells in S phase (Park et al., 2015). In the current
study, increased LAMP-2C levels in human melanomas cells
induced cell cycle checkpoint and DNA damage responses as
suggested by changes in cell cycle distribution (increased G2
and reduced G1 phase cells) with elevated cellular levels of
p21 and activated phospho-Chk1 (Ser345). In melanoma cells
with ectopic LAMP-2C, Chk1 protein abundance increased
twofold while phospho-Chk1 levels were nearly threefold higher
compared with cells transfected with vector alone. This may
reflect the importance of CMA in the turnover of Chk1 in
melanoma cells coupled with stress induced activation of Chk1.
By contrast, induction of DNA damage in murine embryonic
fibroblasts from Atg7- or Atg5-deficient animals with impaired
MA, revealed an increase in proteasome activity, no change in
total Chk1 protein levels, and a significant reduction in phospho-
Chk1 (Ser345) (Liu et al., 2015). The cell cycle regulator p53
is well known to induce the expression of p21 (Giono and
Manfredi, 2006), yet only a slight increase in p53 protein levels
was seen in cells with LAMP-2C expression. p53 is targeted
for degradation by the proteasome and CMA, dependent on
p53 structure and mutations as well as levels of cellular CMA
(Vakifahmetoglu-Norberg et al., 2013). Whether elevated protein
levels of p21 are induced by a p53-dependent or -independent
manner in these melanomas remains to be determined and
is beyond the scope of the current study. The detection of
increased phospho-Chk1 and p21 in melanoma cells with ectopic
LAMP-2C was consistent with increased cell stress, potentially
associated with activation of ROS production and/or DNA
repair mechanisms. Measurements of ROS levels in melanomas
with ectopic LAMP-2C did not reveal a consistent change
compared to control cells. In response to DNA damage, Chk1 is
phosphorylated at Ser345/Ser317. This activated phospho-Chk1
shifts its localization within the nucleus with some molecules
moving into the cytoplasm (Wang et al., 2012). Consistent
with this, experiments here revealed increased Chk1 in the
cytoplasm of cells with ectopic LAMP-2C compared to the
parental melanoma cells. Phospho-Chk1 in the nucleus as well
as the cytoplasm appears to modulate distinct cell checkpoint
events. Studies by Wang et al. (2012) demonstrated diminished
cell viability for Chk1 mutant proteins with increased cytoplasmic
residence.
Xenograft studies revealed LAMP-2C expression in melanoma
cells reduced melanoma growth in vivo. Melanoma xenografts
with high LAMP-2C cellular levels also displayed increased
necrosis, changes in cell morphology, and less cell density in
palpable tumors in stained tissue sections. The increased necrosis
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detected in vivo in tumors expressing LAMP-2C, was consistent
with increased necrosis and apoptosis observed in melanoma
cells with ectopic LAMP-2C in vitro. Immunohistochemistry was
used to examine levels of mitosis in vivo for tumor cells with
and without ectopic LAMP-2C. While no difference in phospho-
Histone H3 was detected in this analysis, differences in tumor
cell morphology and density were again apparent. An analysis
of the effects of LAMP-2A knockdown on lung tumor cells did
not reveal consistent increases in cellular apoptosis compared to
LAMP-2A sufficient cells in vitro, however necrosis and reduced
cell proliferation were noted for xenografts of human lung tumors
with LAMP-2A knockdown (Kon et al., 2011). Together, the
results in this report demonstrate ectopic expression of LAMP-2C
in melanomas disrupted multiple cellular autophagy pathways, as
well as cell cycle progression and survival. While the reductions
in cell growth and increased p21 levels in these melanoma cells
were consistent with decreased CMA and reduced expression
of LAMP-2A, the melanoma cells with increased LAMP-2C
did exhibit some unique differences. These include minimal
changes in p53 protein levels, reduced LAMP-2B expression,
reduced MA, cell cycle arrest, and high levels of Chk1 and
phospho-Chk1. Increased apoptosis and necrosis were detected
for melanomas with increased LAMP-2C expression in vitro
and in vivo. In pilot studies, a highly aggressive triple negative
breast tumor line TMD-231 was also transfected to increased
LAMP-2C expression. No changes in the cell cycle or thymidine
incorporation were observed with the breast tumor line with
or without ectopic LAMP-2C. Thus, additional studies will be
necessary to determine if LAMP-2C expression can modulate
tumor growth and survival beyond melanoma lines. Given the
complexity of cellular changes associated with LAMP-2C, it
may be difficult to definitively pinpoint whether disruptions in
autophagy pathways were linked to alterations in cell cycle and
survival. These studies do, however, highlight a potential role for
LAMP-2C as a tumor suppressor, which might be exploited to
halt melanoma progression.
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